- Home
- HGBL vs CRVO Comparison
HGBL vs CRVO Comparison
Compare HGBL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGBL
- CRVO
- Stock Information
- Founded
- HGBL 1937
- CRVO 2001
- Country
- HGBL United States
- CRVO United States
- Employees
- HGBL N/A
- CRVO N/A
- Industry
- HGBL Business Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- HGBL Consumer Discretionary
- CRVO Health Care
- Exchange
- HGBL Nasdaq
- CRVO Nasdaq
- Market Cap
- HGBL 66.7M
- CRVO 67.4M
- IPO Year
- HGBL N/A
- CRVO N/A
- Fundamental
- Price
- HGBL $1.88
- CRVO $9.99
- Analyst Decision
- HGBL Strong Buy
- CRVO Strong Buy
- Analyst Count
- HGBL 1
- CRVO 6
- Target Price
- HGBL $4.00
- CRVO $19.17
- AVG Volume (30 Days)
- HGBL 43.7K
- CRVO 113.2K
- Earning Date
- HGBL 11-06-2025
- CRVO 08-08-2025
- Dividend Yield
- HGBL N/A
- CRVO N/A
- EPS Growth
- HGBL N/A
- CRVO N/A
- EPS
- HGBL 0.10
- CRVO N/A
- Revenue
- HGBL $48,940,000.00
- CRVO $7,776,968.00
- Revenue This Year
- HGBL $21.54
- CRVO N/A
- Revenue Next Year
- HGBL $4.10
- CRVO N/A
- P/E Ratio
- HGBL $18.97
- CRVO N/A
- Revenue Growth
- HGBL N/A
- CRVO N/A
- 52 Week Low
- HGBL $1.52
- CRVO $1.80
- 52 Week High
- HGBL $2.39
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- HGBL 38.80
- CRVO 55.93
- Support Level
- HGBL $1.86
- CRVO $9.61
- Resistance Level
- HGBL $1.96
- CRVO $10.89
- Average True Range (ATR)
- HGBL 0.07
- CRVO 0.62
- MACD
- HGBL 0.00
- CRVO 0.02
- Stochastic Oscillator
- HGBL 44.44
- CRVO 57.75
About HGBL Heritage Global Inc.
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.